Liquid biopsy is an emerging and non-invasive method of genetic testing, which is applicable to a variety of symptoms and a wide range of applications.
This report contains market size and forecasts of Liquid Tumor Biopsy in Global, including the following market information:
Global Liquid Tumor Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liquid Tumor Biopsy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ctDNA Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid Tumor Biopsy include Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, QIAGEN N.V., Thermo Fisher Scientific, Amoy Diagnostics, HaploX and Whole Genome Sequencing and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liquid Tumor Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Tumor Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liquid Tumor Biopsy Market Segment Percentages, by Type, 2021 (%)
ctDNA
CTC
Global Liquid Tumor Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liquid Tumor Biopsy Market Segment Percentages, by Application, 2021 (%)
Clinical Laboratories
Hospital
Global Liquid Tumor Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liquid Tumor Biopsy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Tumor Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liquid Tumor Biopsy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bio-Rad Laboratories
F. Hoffmann-La Roche
Illumina
QIAGEN N.V.
Thermo Fisher Scientific
Amoy Diagnostics
HaploX
Whole Genome Sequencing
Burning Rock Biotech